Quote:How Robert F. Kennedy Jr. distorted vaccine science
By Seth Mnookin
/January 10, 2017
Robert F. Kennedy Jr. said Tuesday that he will head up a panel on vaccine safety for Donald Trump.
The president-elect’s transition team spokeswoman later walked that back, saying that he is “exploring the possibility” of forming a panel on autism, but “no decisions have been made.”
Let’s hope Trump drops any idea of a vaccine panel headed by Kennedy. For more than a decade, Kennedy has promoted anti-vaccine propaganda completely unconnected to reality. If Kennedy’s panel leads to even a small decline in vaccine rates across the country, it will result in the waste of untold amounts of money and, in all likelihood, the preventable deaths of infants too young to be vaccinated.
That wasted money will largely affect public health departments, whose budgets are already strained. A 2010 study in Pediatrics calculated the public sector expenses of containing a measles outbreak in which 11 children were infected at $124,517, an average of more than $10,000 per infection.
That’s not to say that families won’t be affected as well: During that outbreak, 48 children too young to be vaccinated had to be quarantined at an average cost of $775 per family; medical costs for one infant who was infected were close to $15,000.
But those costs pale into comparison to the loss that will be felt by families who lose children to vaccine-preventable diseases, which typically strike when children are infected while still too young to be vaccinated.
Take pertussis, more commonly known as whooping cough. There have been several dramatic spikes in pertussis infections in the past decade, and in 2012 there were 48,277 reported cases in the US — the most since 1955. More than 87 percent of all of the country’s pertussis deaths from 2000 to 2014 were in infants younger than 3 months, which meant they were too young to have gotten their first pertussis shot.
Kennedy made his name in the anti-vaccine movement in 2005, when he published a story alleging a massive conspiracy regarding thimerosal, a mercury-based preservative that had been removed from all childhood vaccines except for some variations of the flu vaccine in 2001.
In his piece, Kennedy completely ignored an Institute of Medicine immunization safety review on thimerosal published the previous year; he’s also ignored the nine studies funded or conducted by the Centers for Disease Control and Prevention that have taken place since 2003.
I first wrote about Kennedy and his foray into the anti-vaccine movement in “The Panic Virus,” my book about the persistence of the myth that vaccines can cause autism. Below is a lightly edited version of my chapter on Kennedy, titled “A Conspiracy of Dunces.”
While Kennedy has been brazen in publicizing outright lies, he appears to be less loquacious when faced with skeptical reporters. I attempted to contact Kennedy more than 20 times over an 18-month period.
At various points, I was told that he was considering my interview request, that he was on vacation, that he was dealing with a family crisis, that he wasn’t feeling well, that he was behind in his emails, and that he was on the verge of calling me back. (He never did.)
In the summer of 2005, Rolling Stone and Salon simultaneously published “Deadly Immunity,” a 4,700-word story on mercury in vaccines written by Robert F. Kennedy Jr.
Kennedy, the eldest son and namesake of the former attorney general and New York senator, described how he’d come to investigate the issue: “I was drawn into the controversy only reluctantly.
As an attorney and environmentalist who has spent years working on issues of mercury toxicity, I frequently met mothers of autistic children who were absolutely convinced that their kids had been injured by vaccines. Privately, I was skeptical.” [Note: Shortly after “The Panic Virus” was published, Salon decided to pull the piece from its site.]
Then, Kennedy wrote, he began to look at the information these parents had collected. He pored over the transcript from the 2000 CDC-organized meeting outside Atlanta and spoke with members of SafeMinds and Generation Rescue, two groups notable for their virulent opposition to vaccines.
He also studied the work of the “only two scientists” who had managed to gain access to government data on the safety of vaccines: Dr. Mark Geier, a frequent paid witness in lawsuits alleging harm done by vaccines, and his son, David. (The Geiers would go on to develop a “protocol” for treating autism that involved injecting children with the drug that is used to chemically castrate sex offenders at a cost of upwards of $70,000 per year.)
It wasn’t long before Kennedy became convinced that he’d stumbled upon “a chilling case study of institutional arrogance, power and greed.” If, as he believed to be the case, “our public-health authorities knowingly allowed the pharmaceutical industry to poison an entire generation of American children, their actions arguably constitute one of the biggest scandals in the annals of American medicine,” he wrote.
Kennedy went on to quote SafeMinds’ Mark Blaxill, whom he identified as the vice president of “a nonprofit organization concerned about the role of mercury in medicine.” Blaxill accused the CDC of “incompetence and gross negligence” and claimed that the damage done by vaccines was “bigger than asbestos, bigger than tobacco, bigger than anything you’ve ever seen.”
In the article’s final paragraph, Kennedy warned his readers of the scandal’s likely effects on the future: “It’s hard to calculate the damage to our country — and to the international efforts to eradicate epidemic diseases — if Third World nations come to believe that America’s most heralded foreign-aid initiative is poisoning their children.
It’s not difficult to predict how this scenario will be interpreted by American’s enemies abroad.” In fact, he wrote, he was certain that the failure of a generation of “scientists and researchers … to come clean on thimerosal will come back horribly to haunt our country and the world’s poorest populations.”
In order for what Kennedy was claiming to be true, scientists and officials in governmental agencies, nonprofit organizations, and publicly held companies around the world would need to be part of a coordinated multi-decade scheme to prop up “the vaccine industry’s bottom line” by masking the dangers of thimerosal.
In Kennedy’s telling, the plotting had been going on since the Great Depression, but it had begun in renewed earnest five years earlier “at the isolated Simpsonwood conference center,” a location that Kennedy said was chosen because it was “nestled in wooded farmland next to the Chattahoochee River, to ensure complete secrecy.” (In reality, the location was chosen because a series of previously scheduled conferences had booked up all of the hotel rooms within 50 miles of Atlanta.)
Kennedy relied on the 286-page transcript of the Simpsonwood meeting to corroborate his allegations — and wherever the transcript diverged from the story he wanted to tell, he simply cut and pasted until things came out right. Again and again, he used participants’ warnings about the reckless manipulation of scientific data by people with ulterior motives to do the very thing they were afraid would happen.
The CDC’s Robert Chen was one of the victims of Kennedy’s approach. His actual quote is as follows:
“Before we all leave, someone raised a very good process question that all of us as a group needs to address, and that is this information of all the copies we have received and are taking back home to your institutions, to what extent should people feel free to make copies to distribute to others in their organization?
We have been privileged so far that given the sensitivity of information, we have been able to manage to keep it out of, let’s say, less responsible hands, yet the nature of kind of proliferation, and Xerox machines being what they are, the risk of that changes. So I guess as a group perhaps, and Roger [Bernier, the associate director of science at the National Immunization Program], you may have thought about that?”
In Kennedy’s hands, it became this:
“Dr. Bob Chen, head of vaccine safety for the CDC, expressed relief that ‘given the sensitivity of the information, we have been able to keep it out of the hands of, let’s say, less responsible hands.’”
Even more egregious was Kennedy’s slicing and dicing of a lengthy statement by the World Health Organization’s John Clements. In this instance, Kennedy transposed sentences and left out words. Here is what actually appeared in the transcript, with italics added to indicate the sentences Kennedy used in his story:
“And I really want to risk offending everyone in the room by saying that perhaps this study should not have been done at all, because the outcome of it could have, to some extent, been predicted and we have all reached this point now where we are left hanging . . . There is now the point at which the research results have to be handled, and even if this committee decides that there is no association and that information gets out, the work has been done and through Freedom of Information that will be taken by others and will be used in other ways beyond the control of this group.
And I am very concerned about that as I suspect it is already too late to do anything regardless of any professional body and what they say. . . . My message would be that any other study — and I like the study that has just been described here very much, I think it makes a lot of sense — but it has to be thought through. What are the potential outcomes and how will you handle it? How will it be presented to a public and a media that is hungry for selecting the information they want to use for whatever means they have in store for them?”
In “Deadly Immunity,” that was changed to read:
“Dr. John Clements, vaccines advisor at the World Health Organization, declared flatly that the study ‘should not have been done at all’ and warned that the results ‘will be taken by others and will be used in ways beyond the control of this group. The research results have to be handled.’”
To top it all off, Kennedy married together two separate comments made by the developmental biologist and pediatrician Robert Brent. In the first one, Brent said:
“Finally, the thing that concerns me the most, those who know me, I have been a pin stick in the litigation community because of the nonsense of our litigious society. This will be a resource to our very busy plaintiff attorneys in this country when this information becomes available. They don’t want valid data. At least that is my biased opinion. They want business and this could potentially be a lot of business.”
Thirty-eight pages later, Brent addressed the topic of “junk scientists”:
“If an allegation was made that a child’s neurobehavioral findings were caused by thimerosal containing vaccines, you could readily find a junk scientist who would support the claim with ‘a reasonable degree of certainty.’ … So we are in a bad position from the standpoint of defending any lawsuits if they were initiated and I am concerned.”
In a distortion that the editor of a high school newspaper would have balked at, Kennedy took these two statements, switched their order, and ran them together:
“We are in a bad position from the standpoint of defending any lawsuits,” said Dr. Robert Brent, a pediatrician at the Alfred I. DuPont Hospital for Children in Delaware. “This will be a resource to our very busy plaintiff attorneys in this country.”
In the overall scheme of the piece, that type of quote massaging was considered so insignificant that it didn’t warrant inclusion in the more than five hundred words’ worth of “notes,” “clarifications,” and “corrections” that were eventually appended to the piece. (The misuse of Chen’s quote wasn’t acknowledged either.)
Among the issues that were addressed were incorrect attributions, inaccuracies about which vaccines contained thimerosal at different points in time, a misrepresentation of the number of shots children had received in the 1980s, and a false claim about a scientist having a patent on the measles vaccine.
None of this put a dent in Kennedy’s conviction that his allegations were valid, and in the weeks and months to come, he kept on repeating many of the errors Rolling Stone and Salon had already publicly acknowledged were wrong.
Just four days after a correction confirmed that his story had misstated the levels of ethylmercury infants had received — it was actually “40 percent, not 187 times, greater than the EPA’s limit for daily exposure to methyl mercury”— Kennedy told MSNBC’s Joe Scarborough, “We are injecting our children with 400 times the amount of mercury that FDA or EPA considers safe.” Kennedy also said on-air that children were being given 24 vaccines and that each one of them had “this thimerosal, this mercury in them.”
Those statements were not even remotely true: In 2005, the CDC recommended that children under 12 years old receive a total of eight vaccines that protected against a dozen different diseases. Only three of those vaccines had ever used thimerosal as a preservative, and all had been thimerosal-free since 2001.
That Scarborough didn’t ask Kennedy to produce evidence supporting his accusations is not surprising: Scarborough had long had a hunch that vaccines were to blame for his teenage son’s “slight form of autism called Asperger’s.” Kennedy’s research, it seemed, had confirmed his suspicions once and for all. “There’s no doubt in my mind,” Scarborough said, “and maybe it’s two years from now, maybe it’s five years from now, maybe it’s ten years from now — we are going to find out thimerosal causes, in my opinion, autism.”
How Robert F. Kennedy Jr. distorted vaccine science By
Top 10 Most Recent News Articles
York Space Systems Faces Class Action Over Misleading IPO
York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...
Continue Reading
FDI Launches 'Generation Smile' for Global Oral Health
A New Kind of Movement Imagine a campaign not bound by age or geography but united by a shared mission. Generation Smile, freshly launched by the FDI World Dental Federation in Prague, is just that kind of uprising. This initiative redefines existing approaches to oral health, pushing beyond the boundaries of mere dental care to emphasize the integral role oral health...
Continue Reading
Sky Labs' CART Monitor Advances BP Monitoring Tech
Cuffless BP Monitoring: Changing the Game for AF and HF Ever thought a finger ring could revolutionize blood pressure monitoring? Well, welcome to the future—Sky Labs' ring-type CART monitor has just rocked the scene at the ESC Congress 2026 in Munich. This isn't sci-fi, folks; it's where health tech meets reality, and it's shaking the very foundations of how we manage...
Continue Reading
Hims & Hers Faces Class Action: Investors Beware
Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...
Continue Reading
Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins
An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...
Continue Reading
EyePoint Stumbles: Legal Eagles Circle Post-Trial Flop
EyePoint Slips on Clinical Banana Peel Well, if EyePoint was aiming for a splash, they sure got it—just not the kind they were hoping for. News dropped like a lead balloon when EyePoint announced their Phase 3 DURAVYU trial results for wet age-related macular degeneration, revealing they missed their primary endpoint. And what did that mean for their stock? A death...
Continue Reading
TECNO CAMON Slim 5G: Where Art Meets Tech
Unveiling the TECNO CAMON Slim 5G Okay, so imagine a tech brand saying, 'Why not make a phone that’s as much an art piece as it is a gadget?' TECNO just pulled this off with their latest CAMON Slim 5G. The thing's a sleek marvel measuring in at just 6.39mm. Seems like they took a fat-free diet approach to phone design, and not on the digital calories either. A Slim Body...
Continue Reading
ISO 45010: First Guidance for Menstruation, Menopause
Tackling Menstruation and Menopause in the Workplace Today, the International Organization for Standardization (ISO) has taken a bold step forward by launching ISO 45010—a groundbreaking standard aimed at addressing menstruation and menopause in the workplace. Millions endure these natural processes throughout their careers, yet structured policies to support them have...
Continue Reading
China's Manufacturing: Squeeze or Opportunity?
Analyzing China's Impact on Global Markets Think of China's manufacturing clout and you're likely to picture booming factories, relentless steel, and smoke-churning industries reshaping the global chessboard. But here's the kicker: are they swallowing up room for others, or paving the way for their growth? It’s this debate that took the spotlight at the Asia-Pacific...
Continue Reading
Mermaid Folklore Meets Revolution in New Short Film
A Sea Haunting Like No Other Ever feel like history's forgotten tales deserve a fresh spin? Well, this one's shaking it up! Hoyt Dwyer, an Atlanta filmmaker, flips the script on a lesser-known bit from the American Revolution. Yeah, we're talking about Hessian soldiers and sirens here. Just hang on to your hats because this ain't your typical historical retelling. A...
Continue ReadingTop 5 Most Recently Viewed Articles
Angels for Change's Project PROTECT: Mitigating Drug Shortages
Significant Development in Project PROTECT Angels for Change is excited to share a vital update concerning their ongoing initiative, known as Project PROTECT. This project has been designed to proactively address and lessen the impact of severe drug shortages that affect the availability of crucial medications in the United States. By fostering collaborative partnerships...
Continue Reading
Understanding Recent Options Trends for Apollo Global Management
Examining Apollo Global Management’s Recent Options Activity Investors with substantial capital have recently adopted a distinctly bullish outlook on Apollo Global Management. Notably, options history reveals an engaging trend for this prominent asset management firm. In our review of the options market for Apollo Global Management (APO), we identified an impressive 24...
Continue Reading
Tetragon Financial Group Investor Call Highlights and Insights
Join Tetragon Financial Group for a Special Investor Call Tetragon Financial Group Limited will be hosting an important investor call to provide key updates about the company. Set for Wednesday, March 5, at 15:30 GMT / 10:30 EST, this call is a significant opportunity for investors to gain insights into Tetragon's annual report and overall company performance. What to...
Continue Reading
FirstEnergy Reaches Settlement to Enhance Customer Support and Service
FirstEnergy’s Innovative Settlement Shows Dedication to Customers The FirstEnergy Pennsylvania Electric Company (FE PA), a proud part of FirstEnergy Corp. (NYSE: FE), has launched an important settlement during its base rate review process. This $225 million initiative, pending approval from the Pennsylvania Public Utility Commission (PaPUC), represents a key step...
Continue Reading
BioCryst Welcomes Babar Ghias as CFO and Corporate Leader
BioCryst Pharmaceuticals Welcomes New CFO BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX), renowned for its commitment to advancing therapies for rare diseases, has appointed Babar Ghias as its Chief Financial Officer and Head of Corporate Development. His extensive experience in financial management and operational leadership is set to propel the company into its next...
Continue Reading